​​LEF, in compliance with the standards issued by the portuguese authorities, aims to maintain its normal functioning as far as possible, with the adoption of preventive and contingency measures. We have been making efforts to minimize the negative impacts on our busine​ss, customers, employees and other partners. Learn more about the set of measures implemented by LEF in the letter ​sent to all partners.

​​​The deadline for submitting the results of drug products risk assessment containing chemically synthesized active substances (step 1) has been extended from 26 March to 1 October 2020! LEF has a customized consultancy service ready to answer this regulatory challenge.

​​​​LEF has an integrated service offer for the medicinal cannabis market, assisting in the implementation of GACP, GMP, GDP and quality control analysis in accordance with current requirements. ​​​Contact LEF for more information!